Fasting serum adiponectin concentration is reduced in Indo‐Asian subjects and is related to HDL cholesterol
- 7 March 2003
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 5 (2) , 131-135
Abstract
Aims: Adiponectin is a 30‐kDa protein secreted by adipose tissue. The aim of the present study was to compare serum adiponectin in male Indo‐Asian and Caucasian subjects and examine its association with fat topography and metabolic parameters. Methods: Diabetic and non‐diabetic male subjects (n = 48) were studied. A single observer carried out blood pressure and anthropometric measurements. Serum glucose, insulin, lipid profile and adiponectin (measured by RIA) were measured on a fasting sample. Results: There was no statistically significant difference in serum adiponectin between diabetic and BMI‐matched non‐diabetic subjects. However, serum adiponectin was lower in Indo‐Asians compared with BMI‐matched Caucasians, [median adiponectin (interquartile range) 3.3 (2.1–3.9) vs. 4.9 (3.5–6.6) μg/ml respectively (p = 0.016)]. Univariate analysis showed serum adiponectin to be positively associated with HDL in diabetic (p = 0.039) and non‐diabetic subjects (p = 0.0098). Waist circumference (p = 0.02), saggital diameter (p = 0.04) were negatively correlated with serum adiponectin in diabetic subjects. Multiple regression analysis including waist, HDL, fasting insulin, age, diabetes and ethnicity in all subjects showed HDL to be the best predictor of serum adiponectin. Conclusions: Serum adiponectin is associated with HDL cholesterol and central obesity. Caucasians have higher serum adiponectin levels compared with Indo‐Asians. Further studies are needed to explore basis for the association of adiponectin with HDL cholesterol and the reason for lower levels in Indo‐Asians.Keywords
This publication has 30 references indexed in Scilit:
- Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic PatientsDiabetes Care, 2002
- The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2001
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaThe Journal of Clinical Endocrinology & Metabolism, 2001
- An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular WallsHormone and Metabolic Research, 2000
- Etiology of the Metabolic Syndrome: Potential Role of Insulin Resistance, Leptin Resistance, and Other PlayersAnnals of the New York Academy of Sciences, 1999
- The role of TNFα and TNF receptors in obesity and insulin resistanceJournal of Internal Medicine, 1999
- TrueInternational Journal of Obesity, 1998
- Adipose tissue as an endocrine and paracrine organInternational Journal of Obesity, 1998
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996
- The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertensionArchives of internal medicine (1960), 1989